• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Relay Therapeutics Inc (NQ: RLAY )

    6.530 +0.040 (+0.62%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,262,074
    Open 6.560
    Bid (Size) 6.350 (2)
    Ask (Size) 6.690 (24)
    Prev. Close 6.490
    Today's Range 6.381 - 6.630
    52wk Range 5.700 - 12.14
    Shares Outstanding 121,613,181
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week
    The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 which should result in as many as 50 novel therapies being brought to market by then and generate annual... 
    Via Talk Markets
    Why Relay Therapeutics Plummeted by Nearly 14% Today
    Investors weren't happy with the company's latest effort at capital-raising. 
    Via The Motley Fool

    Performance

    YTD
    -44.92%
    -44.92%
    1 Month
    +2.83%
    +2.83%
    3 Month
    +2.67%
    +2.67%
    6 Month
    -5.36%
    -5.36%
    1 Year
    -26.88%
    -26.88%

    More News

    Read More
    Why Relay Therapeutics (RLAY) Stock Is Down 17% Today
    Via Benzinga
    This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
    Via Benzinga
    GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Expert Ratings For Relay Therapeutics
    Via Benzinga
    Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Relay Therapeutics Announces Pricing of Public Offering of Common Stock
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market
    Via Benzinga
    AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th
    Via Talk Markets
    This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
    Via Benzinga
    Dow Jumps Over 1% Following Last Week's Selloff: Investor Sentiment Improves, But Fear & Greed Index Remains In 'Fear' Zone
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Relay Therapeutics Announces Proposed Public Offering of Common Stock
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher
    Via Benzinga
    Exposures Fossil Fuels
    Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July
    Via Benzinga
    Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
    Via Benzinga
    Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    US Stocks Higher; Dow Surges Over 200 Points
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone!
    Via Talk Markets
    Topics Economy
    Exposures Economy
    Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week
    Via Talk Markets
    RLAY Stock Earnings: Relay Therapeutics Beats EPS for Q2 2024
    Via InvestorPlace
    Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.